COVID-19 pandemic
The Danish Health Authority approves the usage of the Molnupiravir antiviral pill developed by Merck & Co. for at-risk patients with symptoms, becoming the first EU country to authorize the usage of this drug.
Sources: NDTV
Changes
- The Danish Health Authority approves an Molnupiravir antiviral pill developed by Merck & Co. for at-risk patients with symptoms, becoming the first in the EU to authorize the drug.
- The Danish Health Authority approves the usage of the Molnupiravir antiviral pill developed by Merck & Co. for at-risk patients with symptoms, becoming the first EU country to authorize the usage of this drug.